seed
Stage
1
Investors
About
Lyric Bio develops proprietary tissue-engineered bioreactors that replicate human biological tissue to produce human immunoglobulin therapies, enabling higher yield and scalable production that reduces dependence on plasma donations.
Explore Lyric Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.